Document Detail


Induction of labor. A double-blind randomized controlled study of prostaglandin E2 vaginal suppositories compared with intranasal oxytocin and with sequential treatment.
MedLine Citation:
PMID:  3885670     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a double-blind randomized controlled study of 300 women, 150 primiparas and 150 multiparas, induction of labor by means of vaginal suppositories containing 3 mg prostaglandin E2 (PGE2) was compared with the conventional method of intranasal oxytocin and with a combined method of 3 mg PGE2 vaginal suppositories alternating with intranasal oxytocin. In the PGE2 group the intensity of delivery was significantly greater than in the oxytocin group, among both primiparas and multiparas and among the patients with ripe and unripe cervix. The efficiency of the combined treatment could no be evaluated because of the high intensity of delivery during the first 24 hours. There were no maternal side effects, and no significant difference in the frequencies of failed induction and cesarean section.
Authors:
B Andreasson; J E Bock; J Larsen
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  64     ISSN:  0001-6349     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  1985  
Date Detail:
Created Date:  1985-05-13     Completed Date:  1985-05-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  157-61     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intranasal
Clinical Trials as Topic
Dinoprostone
Double-Blind Method
Female
Humans
Infant, Newborn
Labor, Induced*
Oxytocin / administration & dosage*
Parity
Pregnancy
Prostaglandins E / administration & dosage*
Random Allocation
Suppositories
Chemical
Reg. No./Substance:
0/Prostaglandins E; 0/Suppositories; 363-24-6/Dinoprostone; 50-56-6/Oxytocin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chlamydia, mycoplasmas, ureaplasmas, and yeasts in the lower genital tract of females. Comparison be...
Next Document:  Serum lipids and lipoproteins in patients with endometrial carcinoma receiving adjuvant treatment wi...